New Key Statistics Module, Z-Score and F-Score
NAS:RVNC Key Ratios
| Market Cap $ M | 411.65 |
| Enterprise Value $ M | 636.17 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 1.43 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 234.00 |
| EPS (TTM) $ | -3.80 |
| Beneish M-Score | -1.71 |
| 10-y EBITDA Growth Rate % | -5.70 |
| 5-y EBITDA Growth Rate % | 0.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.09 |
| EV-to-EBITDA | -2.19 |
| PEG | -- |
| Shares Outstanding M | 104.22 |
| Net Margin (%) | -138.41 |
| Operating Margin % | -95.00 |
| Pre-tax Margin (%) | -138.30 |
| Quick Ratio | 3.29 |
| Current Ratio | 3.80 |
| ROA % (ttm) | -59.15 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -93.31 |
| Dividend Yield % | -- |
| Altman Z-Score | -6.67 |
RVNC Number of Guru Trades
RVNC Volume of Guru Trades
Gurus Latest Trades with NAS:RVNC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RVNC is held by these investors
Total 2
Revance Therapeutics Inc Insider Transactions
No Available Data
News about NAS:RVNC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers